CRESCENT BIOPHARMA, INC. Increase (Decrease) in Accounts Payable
CRESCENT BIOPHARMA, INC. (CBIO) reported Increase (Decrease) in Accounts Payable of -$224.63 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2025-05-14
- CRESCENT BIOPHARMA, INC. increase (decrease) in accounts payable for the quarter ending 2025-03-31 was -$224.63K.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accounts payable for the quarter ending 2024-12-31 was -$252.49K, a 146.91% decline year-over-year.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accounts payable for the quarter ending 2024-09-30 was -$368.97K, a 517.40% decline year-over-year.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accounts payable for the quarter ending 2024-06-30 was $195.23K.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accounts payable for fiscal 2024 was -$538.81K.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accounts payable for fiscal 2023 was -$102.08K.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accounts payable for fiscal 2022 was -$1.14M, a 6534.85% decline from fiscal 2021.
- CRESCENT BIOPHARMA, INC. increase (decrease) in accounts payable for fiscal 2021 was $17.68K, a 97.30% decline from fiscal 2020.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 130 month |
|---|---|---|---|---|---|
| 2025-03-31 | -$224.63K 10-Q · filed 2025-05-14 | -$477.12K derived: sum of 2 quarters · filed 2025-05-14 | -$846.09K derived: sum of 3 quarters · filed 2025-05-14 | -$650.86K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2024-12-31 | -$252.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$621.46K derived: sum of 2 quarters · filed 2025-02-13 | -$426.23K derived: sum of 3 quarters · filed 2025-02-13 | -$538.81K 10-K · filed 2025-02-13 | |
| 2024-09-30 | -$368.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$173.74K derived: sum of 2 quarters · filed 2024-11-13 | -$286.32K 10-Q · filed 2024-11-13 | $251.91K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2024-06-30 | $195.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $82.65K 10-Q · filed 2024-08-08 | $620.88K derived: sum of 3 quarters · filed 2025-05-14 | $709.28K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2024-03-31 | -$112.58K 10-Q · filed 2025-05-14 | $425.65K derived: sum of 2 quarters · filed 2025-05-14 | $514.05K derived: sum of 3 quarters · filed 2025-05-14 | $275.38K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $538.23K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $626.63K derived: sum of 2 quarters · filed 2025-02-13 | $387.96K derived: sum of 3 quarters · filed 2025-02-13 | -$102.08K 10-K · filed 2025-02-13 | |
| 2023-09-30 | $88.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$150.27K derived: sum of 2 quarters · filed 2024-11-13 | -$640.31K 10-Q · filed 2024-11-13 | -$522.24K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | -$238.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$728.70K 10-Q · filed 2024-08-08 | -$610.64K derived: sum of 3 quarters · filed 2024-08-08 | -$1.03M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$490.04K 10-Q · filed 2024-05-09 | -$371.97K derived: sum of 2 quarters · filed 2024-05-09 | -$790.79K derived: sum of 3 quarters · filed 2024-05-09 | -$1.80M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $118.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$300.75K derived: sum of 2 quarters · filed 2024-03-27 | -$1.31M derived: sum of 3 quarters · filed 2024-03-27 | -$1.14M 10-K · filed 2024-03-27 | |
| 2022-09-30 | -$418.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$1.42M derived: sum of 2 quarters · filed 2023-11-03 | -$1.26M 10-Q · filed 2023-11-03 | -$538.31K derived: sum of 4 quarters · filed 2024-03-27 | |
| 2022-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$836.67K 10-Q · filed 2023-08-02 | -$119.49K derived: sum of 3 quarters · filed 2024-03-27 | $96.36K derived: sum of 4 quarters · filed 2024-03-27 | |
| 2022-03-31 | $168.56K 10-Q · filed 2023-05-03 | $885.74K derived: sum of 2 quarters · filed 2024-03-27 | $1.10M derived: sum of 3 quarters · filed 2024-03-27 | $135.37K derived: sum of 4 quarters · filed 2024-03-27 | |
| 2021-12-31 | $717.18K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $933.03K derived: sum of 2 quarters · filed 2024-03-27 | -$33.19K derived: sum of 3 quarters · filed 2024-03-27 | $17.68K 10-K · filed 2024-03-27 | |
| 2021-09-30 | $215.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$750.37K derived: sum of 2 quarters · filed 2022-11-09 | -$699.51K 10-Q · filed 2022-11-09 | $316.82K derived: sum of 4 quarters · filed 2023-03-29 | |
| 2021-06-30 | -$966.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$915.35K 10-Q · filed 2022-08-03 | $100.98K derived: sum of 3 quarters · filed 2023-03-29 | -$190.13K derived: sum of 4 quarters · filed 2023-03-29 | |
| 2021-03-31 | $50.86K 10-Q · filed 2022-04-28 | $1.07M derived: sum of 2 quarters · filed 2023-03-29 | $776.08K derived: sum of 3 quarters · filed 2023-03-29 | -$993.48K derived: sum of 4 quarters · filed 2023-03-29 | |
| 2020-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $725.22K derived: sum of 2 quarters · filed 2023-03-29 | -$1.04M derived: sum of 3 quarters · filed 2023-03-29 | $654.28K 10-K · filed 2023-03-29 | |
| 2020-09-30 | -$291.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$2.06M derived: sum of 2 quarters · filed 2021-11-02 | -$362.05K 10-Q · filed 2021-11-02 | -$333.94K derived: sum of 4 quarters · filed 2022-03-03 | |
| 2020-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$70.94K 10-Q · filed 2021-08-05 | -$42.83K derived: sum of 3 quarters · filed 2022-03-03 | -$1.66M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2020-03-31 | $1.70M 10-Q · filed 2021-05-03 | $1.73M derived: sum of 2 quarters · filed 2022-03-03 | $107.54K derived: sum of 3 quarters · filed 2022-03-03 | $1.30M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2019-12-31 | $28.11K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$1.59M derived: sum of 2 quarters · filed 2022-03-03 | -$395.36K derived: sum of 3 quarters · filed 2022-03-03 | -$1.23M 10-K · filed 2022-03-03 | |
| 2019-09-30 | -$1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$423.47K derived: sum of 2 quarters · filed 2020-11-06 | -$1.26M 10-Q · filed 2020-11-06 | $748.15K derived: sum of 4 quarters · filed 2021-03-02 | |
| 2019-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $363.17K 10-Q · filed 2020-07-31 | $2.37M derived: sum of 3 quarters · filed 2021-03-02 | -$212.76K derived: sum of 4 quarters · filed 2021-03-02 | |
| 2019-03-31 | -$832.56K 10-Q · filed 2020-05-01 | $1.17M derived: sum of 2 quarters · filed 2021-03-02 | -$1.41M derived: sum of 3 quarters · filed 2021-03-02 | -$2.02M derived: sum of 4 quarters · filed 2021-03-02 | |
| 2018-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$575.92K derived: sum of 2 quarters · filed 2021-03-02 | -$1.19M derived: sum of 3 quarters · filed 2021-03-02 | $16.49K 10-K · filed 2021-03-02 | |
| 2018-09-30 | -$2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$3.19M derived: sum of 2 quarters · filed 2019-11-07 | -$1.99M 10-Q · filed 2019-11-07 | -$992.33K derived: sum of 4 quarters · filed 2020-02-28 | |
| 2018-06-30 | -$614.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $592.41K 10-Q · filed 2019-08-01 | $1.59M derived: sum of 3 quarters · filed 2020-02-28 | $2.64M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2018-03-31 | $1.21M 10-Q · filed 2019-05-02 | $2.20M derived: sum of 2 quarters · filed 2020-02-28 | $3.26M derived: sum of 3 quarters · filed 2020-02-28 | $3.33M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2017-12-31 | $995.37K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $2.05M derived: sum of 2 quarters · filed 2020-02-28 | $2.12M derived: sum of 3 quarters · filed 2020-02-28 | $1.06M 10-K · filed 2020-02-28 | |
| 2017-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $1.13M derived: sum of 2 quarters · filed 2018-11-02 | $66.51K 10-Q · filed 2018-11-02 | $384.98K derived: sum of 4 quarters · filed 2019-03-06 | |
| 2017-06-30 | $72.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$990.10K 10-Q · filed 2018-08-09 | -$671.63K derived: sum of 3 quarters · filed 2019-03-06 | -$806.05K derived: sum of 4 quarters · filed 2019-03-06 | |
| 2017-03-31 | -$1.06M 10-Q · filed 2018-05-03 | -$744.58K derived: sum of 2 quarters · filed 2019-03-06 | -$879.00K derived: sum of 3 quarters · filed 2019-03-06 | -$1.07M derived: sum of 4 quarters · filed 2019-03-06 | |
| 2016-12-31 | $318.47K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $184.05K derived: sum of 2 quarters · filed 2019-03-06 | -$6.18K derived: sum of 3 quarters · filed 2019-03-06 | $1.00M 10-K · filed 2019-03-06 | |
| 2016-09-30 | -$134.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$324.65K derived: sum of 2 quarters · filed 2017-11-08 | $682.50K 10-Q · filed 2017-11-08 | $613.65K derived: sum of 4 quarters · filed 2018-03-06 | |
| 2016-06-30 | -$190.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $816.92K 10-Q · filed 2017-08-03 | $748.07K derived: sum of 3 quarters · filed 2018-03-06 | $284.67K derived: sum of 4 quarters · filed 2018-03-06 | |
| 2016-03-31 | $1.01M 10-Q · filed 2017-05-08 | $938.30K derived: sum of 2 quarters · filed 2018-03-06 | $474.91K derived: sum of 3 quarters · filed 2018-03-06 | $397.90K derived: sum of 4 quarters · filed 2018-03-06 | |
| 2015-12-31 | -$68.86K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | -$532.25K derived: sum of 2 quarters · filed 2018-03-06 | -$609.26K derived: sum of 3 quarters · filed 2018-03-06 | -$309.79K 10-K · filed 2018-03-06 | |
| 2015-09-30 | -$463.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$540.40K derived: sum of 2 quarters · filed 2016-11-04 | -$240.94K 10-Q · filed 2016-11-04 | $49.37K derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | -$77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $222.46K 10-Q · filed 2016-08-04 | $512.77K derived: sum of 3 quarters · filed 2017-03-01 | $624.33K derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | $299.46K 10-Q · filed 2016-05-04 | $589.77K derived: sum of 2 quarters · filed 2017-03-01 | $701.33K derived: sum of 3 quarters · filed 2017-03-01 | -$623.55K derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | $290.31K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $401.87K derived: sum of 2 quarters · filed 2017-03-01 | -$923.01K derived: sum of 3 quarters · filed 2017-03-01 | -$270.87K 10-K · filed 2017-03-01 | |
| 2014-09-30 | $111.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$1.21M derived: sum of 2 quarters · filed 2015-11-12 | -$561.18K 10-Q · filed 2015-11-12 | -$1.17M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | -$1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$672.73K 10-Q · filed 2015-08-06 | -$1.28M derived: sum of 3 quarters · filed 2016-02-29 | -$76.40K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $652.15K 10-Q · filed 2015-05-05 | $43.40K derived: sum of 2 quarters · filed 2016-02-29 | $1.25M derived: sum of 3 quarters · filed 2016-02-29 | $1.35M derived: sum of 4 quarters · filed 2016-02-29 | $1.80M 10-Q · filed 2014-05-09 |
| 2013-12-31 | -$608.75K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $596.34K derived: sum of 2 quarters · filed 2016-02-29 | $700.13K derived: sum of 3 quarters · filed 2016-02-29 | $380.70K 10-K · filed 2016-02-29 | |
| 2013-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $1.31M derived: sum of 2 quarters · filed 2014-10-31 | $989.45K 10-Q · filed 2014-10-31 | ||
| 2013-06-30 | $103.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$215.63K 10-Q · filed 2014-07-31 | |||
| 2013-03-31 | -$319.43K 10-Q · filed 2014-05-09 | ||||
| 2012-12-31 | $228.60K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |